Nanoliposomal delivery of cytosolic phospholipase A<sub>2</sub> inhibitor arachidonyl trimethyl ketone for melanoma treatment.

Gowda, Raghavendra; Dinavahi, Saketh S; Iyer, Soumya; Banerjee, Shubhadeep; Neves, Rogerio I; Pameijer, Colette R; Robertson, Gavin P

Nanoliposomal delivery of cytosolic phospholipase A₂ inhibitor arachidonyl trimethyl ketone for melanoma treatment.

Gowda, Raghavendra; Dinavahi, Saketh S; Iyer, Soumya; Banerjee, Shubhadeep; Neves, Rogerio I; Pameijer, Colette R; Robertson, Gavin P.

Afiliación

Gowda R; Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA; The Penn State Melanoma and Skin Cancer Center, The Pennsylvania State University College of Medicine, Hershey, PA; Penn State Melanoma Therapeutics Program, The Pennsylvania State University College of M
Dinavahi SS; Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA.
Iyer S; Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA.
Banerjee S; Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA.
Neves RI; Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA; Department of Dermatology, The Pennsylvania State University College of Medicine, Hershey, PA; Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, PA; The Penn State Mel
Pameijer CR; Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, PA; The Penn State Melanoma and Skin Cancer Center, The Pennsylvania State University College of Medicine, Hershey, PA; Penn State Melanoma Therapeutics Program, The Pennsylvania State University College of Medici
Robertson GP; Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA; Department of Pathology, The Pennsylvania State University College of Medicine, Hershey, PA; Department of Dermatology, The Pennsylvania State University College of Medicine, Hershey, PA; Department of Su

Nanomedicine ; 14(3): 863-873, 2018 04.

Article en En | MEDLINE | ID: mdl-29317343

Asunto(s)

Ácidos Araquidónicos/farmacología; Sistemas de Liberación de Medicamentos; Liposomas/administración & dosificación; Melanoma/tratamiento farmacológico; Nanopartículas/administración & dosificación; Inhibidores de Fosfolipasa A2/farmacología; Fosfolipasas A2 Citosólicas/antagonistas & inhibidores; Animales; Ácidos Araquidónicos/administración & dosificación; Proliferación Celular/efectos de los fármacos; Femenino; Humanos; Liposomas/química; Melanoma/enzimología; Melanoma/patología; Ratones; Ratones Desnudos; Nanopartículas/química; Inhibidores de Fosfolipasa A2/administración & dosificación; Células Tumorales Cultivadas

Palabras clave

Arachidonyl trifluoromethyl ketone and nanoliposomes; Inflammatory cancer; Lipid mediators; Phospholipase A(2); cyclooxygenase

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ácidos Araquidónicos / Sistemas de Liberación de Medicamentos / Nanopartículas / Fosfolipasas A2 Citosólicas / Inhibidores de Fosfolipasa A2 / Liposomas / Melanoma Límite: Animals / Female / Humans Idioma: En Revista: Nanomedicine Asunto de la revista: BIOTECNOLOGIA Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google